Last Updated: May 25, 2026

Details for Luxembourg Supplementary Protection Certificate: LUC00056

« Back to Dashboard

Luxembourg Supplementary Protection Certificate: LUC00056

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	2076541	LUC00056	Luxembourg	PRODUCT NAME: AN ISOLATED ANTIBODY OR FRAGMENT THEREOF COMPRISING LIGHT CHAIN AND HEAVY CHAIN CDR SEQUENCES ACCORDING TO EP-B1-2076541 CLAIM 1 (SEQ ID NOS: 224,225,226 AND 146, 147, 148), WHEREIN THE ANTIBODY OR FRAGMENT THEREOF BINDS HUMAN IL-17 RECEPTOR A; ESPECIALLY AN ANTIBODY COMPRISING THE LIGHT AND HEAVY CHAIN VARIABLE REGION SEQUENCES ACCORDING TO EP-B1-2076541 CLAIM 2 (SEQ ID NOS: 40 AND 14), SUCH AS AN IGG2 ANTIBODY COMPRISING THE LIGHT AND HEAVY CHAIN VARIABLE REGION SEQUENCES ACCORDING TO EP-B1-2076541 CLAIM 2 (SEQ ID NOS: 40 AND 14); AND SPECIFICALLY BRODALUMAB; AND ITS DERIVATES PROTECTED BY EP-B1-2076541; AUTHORISATION NUMBER AND DATE: EU/1/16/1155/001-002 20170719	⤷ Start Trial
>Country	>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Description	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.